Recap: ADMA Biologics Q2 Earnings



ADMA Biologics ADMA reported its Q2 earnings results on Wednesday, August 10, 2022 at 04:00 PM.

Here’s what investors need to know about the announcement.


ADMA Biologics beat estimated earnings by 12.5%, reporting an EPS of $-0.07 versus an estimate of $-0.08.

Revenue was up $16.07 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.02 which was followed by a 17.48% increase in the share price the next day.

Here’s a look at ADMA Biologics’s past performance:


Quarter Q1 2022 Q4 2021 Q3 2021 Q2 2021
EPS Estimate -0.08 -0.09 -0.14 -0.15
EPS Actual -0.10 -0.09 -0.13 -0.14
Revenue Estimate 27.69M 21.76M 18.72M 16.42M
Revenue Actual 29.10M 26.38M 20.68M 17.83M

To track all earnings releases for ADMA Biologics visit their earnings calendar here.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.


Image and article originally from Read the original article here.